First Patient Imaged in NOBLE Registry Mexico
Beginning of March, the Hospital Galenia in the City of Cancun, Mexico, became the fourth center (after University College Hospital, Ibadan in Nigeria, Misr Radiology Center in Egypt and TeleMed Health Services in Australia) to image its first patient within the NOBLE Registry.
Prostate cancer (PCa) is the most common cancer and the leading cause of cancer death in men over 50 years old in Mexico1. Positron emission tomography (PET) with prostate-specific membrane antigen (PSMA) is emerging as the new standard of care worldwide for the diagnosis of prostate cancer. Unfortunately, PET/CT is not as widely available in remote and rural regions, particularly in emerging countries.
It is toward this goal that the NOBLE Registry has been set up, to help enable broad access to advanced diagnostic imaging for every man living with prostate cancer, using PSMA SPECT where PET/CT is not an option.
Principal Investigators in Mexico, Dra Virginia Garcia-Quinto & Dr. Ivan E. Diaz-Meneses, state: “We are so glad to start enrolling patients in the NOBLE Registry in Mexico at Hospital Galenia in the City of Cancun. This represents an enhanced effort to offer and provide molecular imaging for prostate cancer to the most vulnerable men in more regions across the country. We are so proud to support sophisticated medical imaging and the potential it brings to improve patient outcomes.”
Another step in the right direction regarding the advancement of the NOBLE Registry and more importantly to reach the mission of Nobody Left Behind for men living with prostate cancer.